Correlation Between Ardelyx and Cue Biopharma
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Cue Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Cue Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Cue Biopharma, you can compare the effects of market volatilities on Ardelyx and Cue Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Cue Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Cue Biopharma.
Diversification Opportunities for Ardelyx and Cue Biopharma
-0.34 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Ardelyx and Cue is -0.34. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Cue Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cue Biopharma and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Cue Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cue Biopharma has no effect on the direction of Ardelyx i.e., Ardelyx and Cue Biopharma go up and down completely randomly.
Pair Corralation between Ardelyx and Cue Biopharma
Given the investment horizon of 90 days Ardelyx is expected to under-perform the Cue Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Ardelyx is 1.96 times less risky than Cue Biopharma. The stock trades about 0.0 of its potential returns per unit of risk. The Cue Biopharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 156.00 in Cue Biopharma on September 2, 2024 and sell it today you would lose (34.00) from holding Cue Biopharma or give up 21.79% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ardelyx vs. Cue Biopharma
Performance |
| Timeline |
| Ardelyx |
| Cue Biopharma |
Ardelyx and Cue Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ardelyx and Cue Biopharma
The main advantage of trading using opposite Ardelyx and Cue Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Cue Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cue Biopharma will offset losses from the drop in Cue Biopharma's long position.| Ardelyx vs. Tff Pharmaceuticals | Ardelyx vs. Eliem Therapeutics | Ardelyx vs. Inhibrx | Ardelyx vs. Enliven Therapeutics |
| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |